• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

8

CATEGORIES

  • 16
  • 6
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

3
4
17
27

PUBLISHED

1
2
2
27

PRODUCT TYPE

23
4

Search "Viropro, Inc." returned 27 results.

Viropro, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

June 2013
FROM

Psoriatic Arthritis - Pipeline Review, H2 2013

Psoriatic Arthritis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Psoriatic Arthritis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

September 2013
FROM

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2013

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2013', provides an overview...

July 2013
FROM
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies

The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies...

March 2014
FROM

Crohn's Disease - Pipeline Review, H2 2013

Crohn's Disease - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Crohn's Disease - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Ulcerative Colitis - Pipeline Review, H2 2013

Ulcerative Colitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ulcerative Colitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

August 2013
FROM

Arthritis - Pipeline Review, H2 2013

Arthritis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Arthritis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

July 2013
FROM

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014’, provides an overview of the Plaque...

February 2014
FROM

Psoriatic Arthritis - Pipeline Review, H1 2014

Psoriatic Arthritis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2014’, provides an overview of the Psoriatic Arthritis’s therapeutic pipeline. This...

March 2014
FROM

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2014’, provides an overview...

February 2014
FROM

Crohn's Disease - Pipeline Review, H1 2014

Crohn's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Crohn's Disease - Pipeline Review, H1 2014’, provides an overview of the Crohn's Disease’s therapeutic pipeline. This...

February 2014
FROM

Ulcerative Colitis - Pipeline Review, H1 2014

Ulcerative Colitis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2014’, provides an overview of the Ulcerative Colitis’s therapeutic pipeline. This...

February 2014
FROM

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2013

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2013', provides an overview of the indication’s...

July 2013
FROM

Biosimilars (2009 - 2014)

The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities...

September 2009
FROM

Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2013

Spectrum Pharmaceuticals, Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2013” provides data...

April 2013
FROM

Prefilled Syringes Market (3rd Edition), 2015 - 2025

Injectable drug delivery systems have traversed a long way from conventional syringes with vials to prefilled syringes, auto-injectors, pen injectors and needle free systems. These modern devices have...

June 2015
FROM

Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2012

Spectrum Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data...

May 2012
FROM

Breast Cancer - Pipeline Review, H2 2013

Breast Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Breast Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM

Rheumatoid Arthritis - Pipeline Review, H1 2014

Rheumatoid Arthritis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2014’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline. This...

February 2014
FROM

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013 Summary Our "PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers,...

May 2013
FROM
Loading Indicator

Our Clients

Amneal Pharmaceuticals LLC. Amgen Inc. LEO Laboratories Ltd. Pfizer, Inc. Roche Diagnostics Ltd. Merck & Co., Inc. Sanofi S.A.